Today: 24 April 2026
Subscribe
Browse Category

NYSEA:TOVX 15 October 2025

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics (TOVX) Stock Soars 92% on Oncolytic Virus Trial News – Can the Rally Last?

Theriva Biologics shares surged 92% to $0.84 on Oct. 15 after reporting its VCN-01 plus chemotherapy met primary survival endpoints in metastatic pancreatic cancer, prompting a planned Phase 3 trial. The company will present expanded VIRAGE Phase 2b data at ESMO 2025 and interim SYN-004 safety results at IDWeek 2025. Theriva held $12.1 million in cash as of June 30, with a $7.5 million offering closed in May.
15 October 2025

Stock Market Today

  • Arcutis Biotherapeutics (ARQT) Seen Undervalued Amid Mixed Share Price Moves
    April 23, 2026, 8:49 PM EDT. Arcutis Biotherapeutics (ARQT) shares closed at $22.86, down 3.75% in one day and 5.5% over a week, reflecting short-term weakness. However, a 55.3% one-year total shareholder return highlights longer-term gains. The stock trades at a 71% discount to its $39.99 indicated intrinsic value, suggesting potential undervaluation. Key to this outlook is ZORYVE, a topical non-steroidal drug with a promising safety profile and limited systemic exposure. Analyst forecasts hinge on revenue growth and profitability improvement tied to ZORYVE's future adoption. Risks include slower uptake, reimbursement challenges, and ongoing net losses of $16.1 million. Investors are advised to consider the balance of these factors before deciding, amid a volatile healthcare market landscape.

Latest article

Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

Newmont earnings today: Gold miner beats Q1 profit, adds $6 billion buyback but warns on Q2 costs

24 April 2026
Newmont reported adjusted first-quarter earnings of $2.90 per share on $7.31 billion in sales, beating estimates as realized gold prices surged to $4,900 an ounce. Attributable gold output fell to 1.30 million ounces from 1.54 million a year earlier. The miner declared a $0.26 dividend and authorized a new $6 billion share buyback. Newmont expects higher costs and lower output in the second quarter.
SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

SAP Q1 Earnings Beat Forecasts as Cloud Revenue Climbs 27% in Constant Currencies, Outlook Holds

24 April 2026
SAP reported a 17% rise in first-quarter operating profit to 2.74 billion euros and a 19% jump in cloud revenue to 5.96 billion euros, beating forecasts. The company kept its 2026 targets and full-year outlook unchanged. SAP’s U.S. shares reversed losses after the results, climbing nearly 7% in after-hours trading. Management warned cloud revenue growth will slow in the second quarter.
MaxLinear Stock Surges as AI Data-Center Chip Demand Drives Big Q2 Outlook

MaxLinear Stock Surges as AI Data-Center Chip Demand Drives Big Q2 Outlook

24 April 2026
MaxLinear forecast second-quarter revenue of $160 million to $170 million, well above Wall Street’s estimate of $137.1 million. First-quarter revenue rose 43% to $137.2 million, driven by demand for optical products in AI data centers. Shares surged over 23% to $42.47 in after-hours trading. Infrastructure revenue jumped 136% from a year earlier, becoming the company’s largest segment.
Go toTop